EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON QUALITY OF LIFE OF TYPE 2 DIABETES PATIENTS AND ANDROGEN DEFICIENCY

by V. N. Vasilkova, T. V. Mokhort, I. Yu. Pchelin, T. M. Sharshakova, M. V. Zmailik
Published 2016-03-01

EVALUATION OF BONE MINERAL DENSITY IN MALE PATIENTS WITH ANDROGEN DEFICIENCY AND TYPE 2 DIABETES MELLITUS

by V. N. Vasilkova, T. V. Mokhort, I. Yu. Pchelin, T. M. Sharshakova, M. V. Zmailik
Published 2016-07-01

INTERLEUKIN-6 AND DIABETIC NEPHROPATHY: PATHOGENIC INTERCONNECTIONS, TARGETS FOR NEPHROPROTECTION

by I. Yu. Pchelin, V. K. Bayrasheva, A. N. Shishkin, V. N. Vasilkova, N. V. Hudiakova
Published 2017-12-01

EXPERIMENTAL MODELS OF ALIMENTARY OBESITY IN RATS

by V. K. Bayrasheva, I. Y. Pchelin, A. E. Egorova, V. N. Vasilkova, O. V. Kornyushin
Published 2019-11-01

Mechanisms and clinical significance of nephroprotective action of sodium-glucose cotransporter 2 inhibitors

by I. Y. Pchelin, V. N. Vasilkova, A. N. Shishkin, V. K. Bayrasheva, N. V. Hudiakova
Published 2019-01-01

INTEGRATED ASSESSMENT OF THE SUBSTANTIATION FOR MEDICAL CARE TECHNOLOGIES IN TYPE 2 DIABETES PATIENTS WITH ANDROGEN DEFICIENCY

by V. N. Vasilkova, T. V. Mokhort, I. Yu. Pchelin, T. M. Sharshakova, M. V. Zmailik, N. A. Filipcova
Published 2017-08-01

DIAGNOSTIC AND PROGNOSTIC VALUES OF B-TYPE NATRIURETIC PEPTIDES AND N-TERMINAL FRAGMENT BRAIN NATRIURETIC PEPTIDES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISE...

by V. N. Vasilkova, I. Yu. Pchelin, V. K. Bayrasheva, T. V. Mokhort, A. P. Naumenka, N. A. Filiptsova
Published 2018-02-01

NEW PERSPECTIVE FOR THE USE OF SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN DIABETES MELLITUS

by V. K. Bayrasheva, I. Yu. Pchelin, A. N. Arefjeva, P. A. Andoskin, V. N. Vasilkova, D. A. Lebedev, S. G. Chefu
Published 2017-05-01